Expert Opinion comprises eleven phase-specific, peer-reviewed journals for pharmaceutical R&D, from drug discovery to pharmacotherapy. Each journal is tailored to the specific phase of the R&D pipeline it focuses on. Typically, you will find in each issue:

• targeted reviews that assess the current primary research, drawing out the key findings and their applications to clinical practice
  
• in-depth drug evaluations that provide neutral assessments of the pharmacological and clinical properties of new compounds
  
• detailed diagnostic and technology evaluations that provide analysis of individual diagnostics and/or technologies revolutionising the field
  
• thought-provoking editorials that survey developments across the discipline and flag up potentially interesting areas for further research
  
• patent evaluations that analyse the aims, chemistry and biological claims of individual patents
  
• original research articles reporting the original results of clinical investigations on agents that are in Phase III and IV clinical trials